Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $106,010 | 59 | 67.0% |
| Food and Beverage | $27,037 | 1,015 | 17.1% |
| Consulting Fee | $19,030 | 6 | 12.0% |
| Travel and Lodging | $6,114 | 15 | 3.9% |
| Education | $77.29 | 11 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $101,161 | 203 | $0 (2024) |
| Gilead Sciences, Inc. | $20,999 | 205 | $0 (2024) |
| Axsome Therapeutics, Inc. | $19,054 | 26 | $0 (2024) |
| ABBVIE INC. | $2,383 | 102 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $2,280 | 1 | $0 (2024) |
| ViiV Healthcare Company | $1,453 | 55 | $0 (2024) |
| Lundbeck LLC | $1,245 | 67 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $949.62 | 60 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $899.79 | 36 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $728.66 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61,291 | 222 | Alkermes, Inc. ($30,388) |
| 2023 | $23,500 | 192 | Gilead Sciences, Inc. ($11,068) |
| 2022 | $32,480 | 221 | Alkermes, Inc. ($28,594) |
| 2021 | $34,127 | 183 | Alkermes, Inc. ($31,451) |
| 2020 | $976.38 | 52 | Gilead Sciences, Inc. ($257.38) |
| 2019 | $2,903 | 98 | Gilead Sciences, Inc. ($741.49) |
| 2018 | $1,888 | 66 | Alkermes, Inc. ($601.20) |
| 2017 | $1,103 | 72 | Collegium Pharmaceutical, Inc. ($188.30) |
All Payment Transactions
1,106 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: CNS | ||||||
| 12/18/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REJOYN (Device) | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.45 | General |
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $1.62 | General |
| 12/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $5.56 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Alkermes, Inc. | VIVITROL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,370.00 | General |
| Category: CNS | ||||||
| 11/22/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: CNS | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: HIV | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/20/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $119.63 | General |
| Category: CNS | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $34.33 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.24 | General |
| 11/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $4.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $1.10 | General |
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $35.42 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $3.23 | General |
| 11/04/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 87 | 239 | $47,791 | $20,044 |
| 2022 | 2 | 65 | 176 | $31,734 | $15,516 |
| 2021 | 2 | 72 | 182 | $31,459 | $16,549 |
| 2020 | 3 | 76 | 203 | $32,825 | $13,801 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 174 | $33,136 | $13,178 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 65 | $14,655 | $6,866 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 132 | $22,507 | $10,428 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 44 | $9,227 | $5,088 | 55.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 134 | $22,200 | $11,044 | 49.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 48 | $9,259 | $5,505 | 59.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 132 | $21,175 | $8,626 | 40.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 42 | $7,720 | $3,936 | 51.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 29 | $3,930 | $1,239 | 31.5% |
About Dr. Matthew Pabis, M.D
Dr. Matthew Pabis, M.D is a Family Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1376981589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Pabis, M.D has received a total of $158,268 in payments from pharmaceutical and medical device companies, with $61,291 received in 2024. These payments were reported across 1,106 transactions from 65 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($106,010).
As a Medicare-enrolled provider, Pabis has provided services to 300 Medicare beneficiaries, totaling 800 services with total Medicare billing of $65,910. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location New York, NY
- Active Since 06/10/2013
- Last Updated 01/09/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376981589
Products in Payments
- VIVITROL (Drug) $89,029
- Auvelity (Drug) $19,054
- Epclusa (Drug) $11,909
- Vivitrol (Drug) $10,451
- REJOYN (Device) $2,280
- VRAYLAR (Drug) $1,237
- REXULTI (Drug) $1,162
- ARISTADA (Drug) $892.53
- APRETUDE (Biological) $762.33
- CAPLYTA (Drug) $723.10
- DOVATO (Drug) $690.32
- Otezla (Drug) $580.65
- ABILIFY MAINTENA (Drug) $566.47
- Zubsolv (Drug) $532.84
- TRINTELLIX (Drug) $522.88
- RELISTOR (Drug) $519.06
- UBRELVY (Drug) $381.98
- Aristada 441 mg (Drug) $360.92
- MAVYRET (Drug) $331.10
- INVEGA SUSTENNA (Drug) $309.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in New York
Larry Neuman
Family Medicine — Payments: $402,354
Dr. Alexander Blinski, M.d, M.D
Family Medicine — Payments: $139,722
Jason Kindt, D.o, D.O
Family Medicine — Payments: $100,211
Anthony Lyon, M.d, M.D
Family Medicine — Payments: $66,639
Dr. Daniel Bowers, M.d, M.D
Family Medicine — Payments: $62,819
Dr. Mahyar Eidgah, M.d, M.D
Family Medicine — Payments: $60,808